Dubai's Economic Security Centre, Dubai Free Zones Council, and Emirates NBD have signed a trilateral partnership to streamline business operations and enhance the investor experience.
Generate Biomedicines Inc is set to launch its IPO on the Nasdaq exchange tomorrow.
Kyndryl investors face a critical April 13 deadline in a class action lawsuit over financial misstatements and internal controls.
Zynex investors have until April 21, 2026, to seek the role of lead plaintiff in a federal securities class action.
Elbit Systems Ltd (NASDAQ:ESLT) has seen a 19.7% drop in short interest, signaling a shift in investor sentiment.
The State Street SPDR NYSE Technology ETF (XNTK) has seen renewed interest as the tech sector continues to show resilience despite market fluctuations.
China is the world's largest producer and consumer of wind turbines, with 94% of its installed capacity used domestically.
Sebi will require mutual funds to use domestic spot prices for valuing physical gold and silver from 2026.
Prediction markets have exploded in 2024, with billions wagered on US election outcomes as platforms like Polymarket and Kalshi reshape the financial landscape.
IRFC shares rose nearly 1% as OFS opens for retail investors, with institutional bids accounting for 94.98% of shares.
Va Tech Wabag Ltd, a global water technology company, has seen a 58% compounded return in three years and is now rated a buy with a 30% upside potential.
Bitcoin may be forming a price structure similar to the one that marked the end of the 2018 bear market, according to crypto analyst Osemka, who suggests the current setup could signal a potential bottom.
Abbott India Ltd, a key subsidiary of US-based Abbott Laboratories, is quietly gaining traction in India's pharmaceutical market, offering US investors a unique opportunity in a domestic-focused, high-ROE business that remains largely overlooked.
Bitcoin surged over $2,000 ahead of Donald Trump's State of the Union address, but Peter Schiff warns the rally may be short-lived speculation.
APEMARS ($APRZ) is capturing investor attention as its presale enters a critical stage, offering a projected 6,900% return on investment, while Bitcoin faces pressure and XRP experiences a surge in transaction volume.